摘要 |
FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to tricyclic diazepine antagonists of vasopressin and oxytocin of the general formula (I) <EMI ID=0.303 HE=27 WI=39 TI=CHI> where Y means -(CH<SB>2</SB>)<SB>n</SB> where n = 0 or 1; A-B means -NR<SP>3</SP>-(CH<SB>2</SB>)<SB>m</SB>- where m = 1 or 2 and fragment <EMI ID=0.304 HE=15 WI=15 TI=CHI> means condensed phenyl, 5-membered aromatic (unsaturated) heterocyclic ring containing one sulfur heteroatom. Fragment <EMI ID=0.305 HE=15 WI=15 TI=CHI> means 5-membered heterocyclic, unsaturated, condensed ring containing nitrogen atom where D, E and F are taken from carbon or nitrogen atoms and where carbon atoms can be optionally substituted with substituents taken from halogen atom, <EMI ID=0.306 HE=9 WI=12 TI=CHI>, -C(O)O-lower-(C<SB>1</SB>-C<SB>3</SB>)-alkyl and others; substituent R means a fragment of the formula <EMI ID=0.307 HE=9 WI=15 TI=CHI> where Ar means a residue <EMI ID=0.308 HE=18 WI=21 TI=CHI> where R and R are hydrogen, lower-(C<SB>1</SB>-C<SB>3</SB>)-alkyl, lower-(C<SB>1</SB>-C<SB>3</SB>)-alkoxy-group and halogen atom. Compound is taken from fragments of formulas <EMI ID=0.309 HE=6 WI=66 TI=CHI> and others where R<SB>a</SB> is hydrogen, CH<SB>2</SB> or <EMI ID=0.310 HE=15 WI=27 TI=CHI>; q = 1; R<SB>b</SB> is CH<SB>3</SB> or C<SB>2</SB>H<SB>5</SB>; <EMI ID=0.311 HE=3 WI=6 TI=CHI> is taken from fragments of formulas <EMI ID=0.312 HE=21 WI=72 TI=CHI> where <EMI ID=0.313 HE=3 WI=3 TI=CHI> means S; R and R are taken independently from hydrogen atom, lower-(C<SB>1</SB>-C<SB>3</SB>)-alkyl, -S-lower-(C<SB>1</SB>-C<SB>3</SB>)-alkyl, halogen atom, OH, NO<SB>2</SB>, -O-lower-(C<SB>1</SB>-C<SB>3</SB>)-alkyl, CF<SB>3</SB>; R is taken from hydrogen, halogen atoms, lower-(C<SB>1</SB>-C<SB>3</SB>)-alkyl, and its pharmaceutically acceptable salts and prodrugs. Method of synthesis of compounds of the formula (I) involves an interaction of compound of the formula (II) <EMI ID=0.314 HE=27 WI=42 TI=CHI> with compound of the formula Ar-C(O)-Q where subst
|